Phoenix Secures $15M In Contracts To Deliver Nuclear Fuel Inspection Solutions

Phoenix recently signed an agreement to provide two nuclear fuel inspection systems for a major US company that provides a wide range of nuclear power plant products and services throughout the world. This comes just days after concluding and passing a key preliminary testing milestone under an existing contract with another US-based nuclear fuel manufacturer. The total value of these contracts is more than $15M.

"This represents a big step forward for the nuclear fuel industry as they move away from dependence on Californium-252, a radioactive material with serious cost and supply concerns," Evan Sengbusch, Phoenix LLC President said. "These important commercial agreements are representative of the growth we've seen this past year," he said. In the past year, Phoenix has doubled its staff to over 100 full and part time employees.

Phoenix's technology provides a high-flux, electronic neutron source that is a viable alternative for applications such as neutron imaging and nuclear fuel scanning that previously required nuclear reactors or radioisotopes. It is currently being adopted by government and commercial customers as a safer and more cost effective alternative for a broad range of applications in healthcare, energy, and defense.

The fuel scanners Phoenix will deliver validate that every fuel rod that goes into a nuclear reactor meets its design specifications, specifically that the fuel pellets contain uranium of appropriate enrichment.  This ensures that reactors continue to operate efficiently and safely.

"Phoenix is building a track record of developing industry-disrupting technology," said Ross Radel, Phoenix CEO, referencing their accelerator-based neutron imaging systems, which is enabling neutron imaging in production settings, eliminating the logistical and cost burden associated with shipping parts to nuclear reactors.  "We look forward to building on these contracts to further support the nuclear energy industry."

Phoenix Raises $12M in Growth Capital


Phoenix Nuclear Labs announced that it has closed on $12M in funding to support its next stage of growth. In conjunction with the financing close, the company’s name has changed to “Phoenix,” as it continues to expand its breadth of product offerings across healthcare, nuclear and solar energy, semiconductor processing, industrial imaging, and defense.

The round was led by New York-based Deerfield Management Company, a healthcare investment firm with over $8B under management.  “We have worked with the Phoenix management team over the course of two years leading up to our investment, and we have great confidence in its ability to execute its vision and continue to grow Phoenix into a leading global technology company,” said Steve Hochberg, a Partner on the Private Transactions team at Deerfield.

Additional funds were raised from several Wisconsin-based investment firms that have previously invested in the company.

“The strong interest in this funding round from our existing investor base and the participation of a well-respected and experienced investment firm like Deerfield is a great testament to the work our team has done to mature our technology and increase our market penetration over the last two years,” said Ross Radel, President of Phoenix. “This near-term influx of capital and the vast resources that Deerfield brings to the table will be critical in fueling the personnel and infrastructure investments needed to accelerate our growth.”

During the past two years, Phoenix’s revenue has increased more than five-fold. The company has grown from 23 employees at the beginning of 2016 to 56 employees today.  They intend to add approximately 30 additional employees through the end of 2018.

Phoenix recently signed a lease on a new building near its Monona, WI headquarters that will double its office, manufacturing, and laboratory space.  The company has announced plans to build a new manufacturing facility in the greater Madison area that will serve as its global headquarters beginning in the spring of 2019.

Phoenix to supply Rayton Solar with technology for low-cost solar panel production

Monona, Wis. – Phoenix has signed a long-term agreement to be the exclusive supplier of high current proton accelerators to California-based Rayton Solar to produce low cost, high efficiency solar panels. Under the terms of the agreement, Phoenix will deliver the first system to Rayton at the end of 2017, followed by several additional units in 2018 and 2019.


Gregory OD Smith Joins SHINE’s Board of Directors

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory OD Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly-99) and other medical isotopes.